Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 261

1.

Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer.

Lumme S, Tenkanen L, Langseth H, Gislefoss R, Hakama M, Stattin P, Hallmans G, Adlercreutz H, Saikku P, Stenman UH, Tuohimaa P, Luostarinen T, Dillner J.

Acta Oncol. 2016 Jul;55(7):839-45. doi: 10.3109/0284186X.2016.1139178. Epub 2016 Feb 15.

PMID:
26878091
2.

Gene expression profiles in human and mouse primary cells provide new insights into the differential actions of vitamin D3 metabolites.

Tuohimaa P, Wang JH, Khan S, Kuuslahti M, Qian K, Manninen T, Auvinen P, Vihinen M, Lou YR.

PLoS One. 2013 Oct 8;8(10):e75338. doi: 10.1371/journal.pone.0075338. eCollection 2013. Erratum in: PLoS One. 2013;8(11). doi:10.1371/annotation/9cb2000b-a962-453c-ad8b-088f91095f6d.

3.

Optimal serum calcidiol concentration for cancer prevention.

Tuohimaa P, Lou YR.

Anticancer Res. 2012 Jan;32(1):373-81. Review.

PMID:
22213329
4.

Expression and vitamin D3 regulation of long-chain fatty-acid-CoA ligase 3 in human prostate cancer cells.

Qiao S, Tuohimaa P.

Prostaglandins Leukot Essent Fatty Acids. 2011 Jan-Feb;84(1-2):19-23. doi: 10.1016/j.plefa.2010.10.001. Epub 2010 Oct 30.

PMID:
21041072
5.

Spore film dosimeters are feasible for UV dose monitoring during heliotherapy.

Vähävihu K, Ylianttila L, Kautiainen H, Tuohimaa P, Reunala T, Snellman E.

Photochem Photobiol. 2010 Sep-Oct;86(5):1174-8. doi: 10.1111/j.1751-1097.2010.00769.x.

PMID:
20573044
6.

Neurosteroid vitamin D system as a nontraditional drug target in neuropsychopharmacology.

Stewart A, Wong K, Cachat J, Elegante M, Gilder T, Mohnot S, Wu N, Minasyan A, Tuohimaa P, Kalueff AV.

Behav Pharmacol. 2010 Sep;21(5-6):420-6. doi: 10.1097/FBP.0b013e32833c850f. Review.

PMID:
20571365
7.

Niacin in the prevention of atherosclerosis: Significance of vasodilatation.

Tuohimaa P, Järvilehto M.

Med Hypotheses. 2010 Oct;75(4):397-400. doi: 10.1016/j.mehy.2010.04.007. Epub 2010 May 7.

PMID:
20452129
8.

Narrowband ultraviolet B course improves vitamin D balance in women in winter.

Vähävihu K, Ylianttila L, Kautiainen H, Viljakainen H, Lamberg-Allardt C, Hasan T, Tuohimaa P, Reunala T, Snellman E.

Br J Dermatol. 2010 Apr;162(4):848-53. doi: 10.1111/j.1365-2133.2010.09629.x. Epub 2010 Jan 22.

PMID:
20105173
9.

The effects of storage time and sampling season on the stability of serum 25-hydroxy vitamin D and androstenedione.

Agborsangaya C, Toriola AT, Grankvist K, Surcel HM, Holl K, Parkkila S, Tuohimaa P, Lukanova A, Lehtinen M.

Nutr Cancer. 2010;62(1):51-7. doi: 10.1080/01635580903191460.

PMID:
20043259
10.

Serum 25-hydroxyvitamin D at pregnancy and risk of breast cancer in a prospective study.

Agborsangaya CB, Surcel HM, Toriola AT, Pukkala E, Parkkila S, Tuohimaa P, Lukanova A, Lehtinen M.

Eur J Cancer. 2010 Feb;46(3):467-70. doi: 10.1016/j.ejca.2009.11.019.

PMID:
20022237
11.

25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand.

Lou YR, Molnár F, Peräkylä M, Qiao S, Kalueff AV, St-Arnaud R, Carlberg C, Tuohimaa P.

J Steroid Biochem Mol Biol. 2010 Feb 15;118(3):162-70. doi: 10.1016/j.jsbmb.2009.11.011. Epub 2009 Nov 26.

PMID:
19944755
12.

Serum 25-hydroxyvitamin D and the risk of ovarian cancer.

Toriola AT, Surcel HM, Agborsangaya C, Grankvist K, Tuohimaa P, Toniolo P, Lukanova A, Pukkala E, Lehtinen M.

Eur J Cancer. 2010 Jan;46(2):364-9. doi: 10.1016/j.ejca.2009.08.002. Epub 2009 Aug 25.

PMID:
19713101
13.

Vitamin D, nervous system and aging.

Tuohimaa P, Keisala T, Minasyan A, Cachat J, Kalueff A.

Psychoneuroendocrinology. 2009 Dec;34 Suppl 1:S278-86. doi: 10.1016/j.psyneuen.2009.07.003. Review.

PMID:
19660871
14.

Premature aging in vitamin D receptor mutant mice.

Keisala T, Minasyan A, Lou YR, Zou J, Kalueff AV, Pyykkö I, Tuohimaa P.

J Steroid Biochem Mol Biol. 2009 Jul;115(3-5):91-7. doi: 10.1016/j.jsbmb.2009.03.007. Epub 2009 Mar 31.

PMID:
19500727
15.

Vitamin D and aging.

Tuohimaa P.

J Steroid Biochem Mol Biol. 2009 Mar;114(1-2):78-84. Review.

PMID:
19444937
16.

Vestibular dysfunction in vitamin D receptor mutant mice.

Minasyan A, Keisala T, Zou J, Zhang Y, Toppila E, Syvälä H, Lou YR, Kalueff AV, Pyykkö I, Tuohimaa P.

J Steroid Biochem Mol Biol. 2009 Apr;114(3-5):161-6. doi: 10.1016/j.jsbmb.2009.01.020. Epub 2009 Feb 6.

PMID:
19429446
17.

Serum cholesterol and expression of ApoAI, LXRbeta and SREBP2 in vitamin D receptor knock-out mice.

Wang JH, Keisala T, Solakivi T, Minasyan A, Kalueff AV, Tuohimaa P.

J Steroid Biochem Mol Biol. 2009 Feb;113(3-5):222-6. doi: 10.1016/j.jsbmb.2009.01.003. Epub 2009 Jan 20.

PMID:
19429425
18.

Vasa vasorum hypoxia: initiation of atherosclerosis.

Järvilehto M, Tuohimaa P.

Med Hypotheses. 2009 Jul;73(1):40-1. doi: 10.1016/j.mehy.2008.11.046. Epub 2009 Mar 4.

PMID:
19264413
19.

Vitamin D, aging, and cancer.

Tuohimaa P.

Nutr Rev. 2008 Oct;66(10 Suppl 2):S147-52. doi: 10.1111/j.1753-4887.2008.00095.x. Review.

PMID:
18844842
20.

Heliotherapy improves vitamin D balance and atopic dermatitis.

Vähävihu K, Ylianttila L, Salmelin R, Lamberg-Allardt C, Viljakainen H, Tuohimaa P, Reunala T, Snellman E.

Br J Dermatol. 2008 Jun;158(6):1323-8. doi: 10.1111/j.1365-2133.2008.08518.x. Epub 2008 Mar 20.

PMID:
18363748
21.

Progressive hearing loss in mice with a mutated vitamin D receptor gene.

Zou J, Minasyan A, Keisala T, Zhang Y, Wang JH, Lou YR, Kalueff A, Pyykkö I, Tuohimaa P.

Audiol Neurootol. 2008;13(4):219-30. doi: 10.1159/000115431. Epub 2008 Feb 7.

PMID:
18259074
22.

The regular and light-dark Suok tests of anxiety and sensorimotor integration: utility for behavioral characterization in laboratory rodents.

Kalueff AV, Keisala T, Minasyan A, Kumar SR, LaPorte JL, Murphy DL, Tuohimaa P.

Nat Protoc. 2008;3(1):129-36. doi: 10.1038/nprot.2007.516.

PMID:
18193029
23.

Calcitriol and TO-901317 interact in human prostate cancer LNCaP cells.

Wang JH, Tuohimaa P.

Gene Regul Syst Bio. 2008 Mar 17;2:97-105.

24.

Analyzing grooming microstructure in neurobehavioral experiments.

Kalueff AV, Aldridge JW, LaPorte JL, Murphy DL, Tuohimaa P.

Nat Protoc. 2007;2(10):2538-44.

PMID:
17947996
25.

Involvement of nuclear progesterone receptors in the formation of anxiety in female mice.

Galeeva AY, Pivina SG, Tuohimaa P, Ordyan NE.

Neurosci Behav Physiol. 2007 Oct;37(8):843-8.

PMID:
17922250
26.

An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men.

Laaksi I, Ruohola JP, Tuohimaa P, Auvinen A, Haataja R, Pihlajamäki H, Ylikomi T.

Am J Clin Nutr. 2007 Sep;86(3):714-7.

PMID:
17823437
27.

Pharmacological modulation of anxiety-related behaviors in the murine Suok test.

Kalueff AV, Keisala T, Minasyan A, Tuohimaa P.

Brain Res Bull. 2007 Sep 14;74(1-3):45-50. Epub 2007 May 29.

PMID:
17683788
28.
29.

Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.

Tuohimaa P, Pukkala E, Scélo G, Olsen JH, Brewster DH, Hemminki K, Tracey E, Weiderpass E, Kliewer EV, Pompe-Kirn V, McBride ML, Martos C, Chia KS, Tonita JM, Jonasson JG, Boffetta P, Brennan P.

Eur J Cancer. 2007 Jul;43(11):1701-12. Epub 2007 May 30.

PMID:
17540555
30.

Neophobia, sensory and cognitive functions, and hedonic responses in vitamin D receptor mutant mice.

Minasyan A, Keisala T, Lou YR, Kalueff AV, Tuohimaa P.

J Steroid Biochem Mol Biol. 2007 May;104(3-5):274-80. Epub 2007 Mar 24.

PMID:
17482806
31.

Aberrant nest building and prolactin secretion in vitamin D receptor mutant mice.

Keisala T, Minasyan A, Järvelin U, Wang J, Hämäläinen T, Kalueff AV, Tuohimaa P.

J Steroid Biochem Mol Biol. 2007 May;104(3-5):269-73. Epub 2007 Mar 24.

PMID:
17467982
32.

Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer.

Tuohimaa P, Tenkanen L, Syvälä H, Lumme S, Hakulinen T, Dillner J, Hakama M.

Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):302-7.

33.

[Participation of progesterone receptors in plus-maze behavior in female mice].

Galeeva AIu, Pivina SG, Tuohimaa P, Ordian NE.

Ross Fiziol Zh Im I M Sechenova. 2006 Jul;92(7):843-51. Russian.

PMID:
17300041
34.

Neurosteroid hormone vitamin D and its utility in clinical nutrition.

Kalueff AV, Tuohimaa P.

Curr Opin Clin Nutr Metab Care. 2007 Jan;10(1):12-9. Review.

PMID:
17143049
35.

Influence of paternal genotypes on F1 behaviors: lessons from several mouse strains.

Kalueff AV, Keisala T, Minasyan A, Tuohimaa P.

Behav Brain Res. 2007 Feb 12;177(1):45-50. Epub 2006 Dec 4.

PMID:
17141884
36.

Association between serum 25(OH)D concentrations and bone stress fractures in Finnish young men.

Ruohola JP, Laaksi I, Ylikomi T, Haataja R, Mattila VM, Sahi T, Tuohimaa P, Pihlajamäki H.

J Bone Miner Res. 2006 Sep;21(9):1483-8.

37.

The vitamin D neuroendocrine system as a target for novel neurotropic drugs.

Kalueff AV, Minasyan A, Keisala T, Kuuslahti M, Miettinen S, Tuohimaa P.

CNS Neurol Disord Drug Targets. 2006 Jun;5(3):363-71. Review.

PMID:
16787236
38.

Regulation of cholesterol 25-hydroxylase expression by vitamin D3 metabolites in human prostate stromal cells.

Wang JH, Tuohimaa P.

Biochem Biophys Res Commun. 2006 Jun 30;345(2):720-5. Epub 2006 May 5.

PMID:
16696936
39.

Altered levels of Smad2 and Smad4 are associated with human prostate carcinogenesis.

Perttu MC, Martikainen PM, Huhtala HS, Bläuer M, Tammela TL, Tuohimaa PJ, Syvälä H.

Prostate Cancer Prostatic Dis. 2006;9(2):185-9. Epub 2006 Mar 21.

PMID:
16550207
40.

Androgen enhances the antiproliferative activity of vitamin D3 by suppressing 24-hydroxylase expression in LNCaP cells.

Lou YR, Tuohimaa P.

J Steroid Biochem Mol Biol. 2006 Apr;99(1):44-9. Epub 2006 Mar 9.

PMID:
16524720
41.

Vitamin D fortification as public health policy: significant improvement in vitamin D status in young Finnish men.

Laaksi IT, Ruohola JP, Ylikomi TJ, Auvinen A, Haataja RI, Pihlajamäki HK, Tuohimaa PJ.

Eur J Clin Nutr. 2006 Aug;60(8):1035-8. Epub 2006 Feb 15.

PMID:
16482069
42.

Temporal stability of novelty exploration in mice exposed to different open field tests.

Kalueff AV, Keisala T, Minasyan A, Kuuslahti M, Tuohimaa P.

Behav Processes. 2006 Mar;72(1):104-12. Epub 2006 Jan 26.

PMID:
16442749
43.

Behavioural anomalies in mice evoked by "Tokyo" disruption of the Vitamin D receptor gene.

Kalueff AV, Keisala T, Minasyan A, Kuuslahti M, Miettinen S, Tuohimaa P.

Neurosci Res. 2006 Apr;54(4):254-60. Epub 2006 Jan 19.

PMID:
16427152
44.

Retinoic acid via RARalpha inhibits the expression of 24-hydroxylase in human prostate stromal cells.

Lou YR, Miettinen S, Kagechika H, Gronemeyer H, Tuohimaa P.

Biochem Biophys Res Commun. 2005 Dec 30;338(4):1973-81. Epub 2005 Nov 7.

PMID:
16289102
45.

Increased severity of chemically induced seizures in mice with partially deleted Vitamin D receptor gene.

Kalueff AV, Minasyan A, Keisala T, Kuuslahti M, Miettinen S, Tuohimaa P.

Neurosci Lett. 2006 Feb 6;394(1):69-73. Epub 2005 Oct 25.

PMID:
16256271
46.

Hair barbering in mice: implications for neurobehavioural research.

Kalueff AV, Minasyan A, Keisala T, Shah ZH, Tuohimaa P.

Behav Processes. 2006 Jan 10;71(1):8-15. Epub 2005 Oct 19.

PMID:
16236465
47.
48.

Behavioural characterization in rats using the elevated alley Suok test.

Kalueff AV, Minasyan A, Tuohimaa P.

Behav Brain Res. 2005 Nov 30;165(1):52-7. Epub 2005 Sep 6.

PMID:
16144722
49.

Anticonvulsant effects of 1,25-dihydroxyvitamin D in chemically induced seizures in mice.

Kalueff AV, Minasyan A, Tuohimaa P.

Brain Res Bull. 2005 Sep 30;67(1-2):156-60.

PMID:
16140175
50.

Abnormal behavioral organization of grooming in mice lacking the vitamin D receptor gene.

Kalueff AV, Lou YR, Laaksi I, Tuohimaa P.

J Neurogenet. 2005 Jan-Mar;19(1):1-24.

PMID:
16076629

Supplemental Content

Loading ...
Support Center